Sirakoss wins the Venture Prize from the Worshipful Company of Armourers and Brasiers.

Patented novel packaging prevents food poisoning from eating fresh produce.

Brace Pharma has invested $15m in cancer drug developer Tyrogenex, which will use the funding to advance its lead product.

Reminova, a new King's spin-out, will do away with cavities.

Cambia Health joined the backers of ClearCare, which include returning investor Qualcomm, as it raised its overall funding to $15.5m.

Cisco is buying network automation software producer Tail-F in a $175m deal that will provide an exit to SEB Venture Capital, which led its series A and B rounds.

The biotechnology company, backed by AbbVie and Abbott Biotech in earlier rounds, has closed a series C round that will be directed towards its nucleic acid-based treatments.